Skip to main content
    O

    OKYO Pharma Limited (OKYO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.10
    -0.08 (-6.38%)

    Market Cap: $70.85M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    OKYO Pharma Limited (OKYO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    OKYO Pharma (OKYO) has a latest price of $1.10 on Nov 17, 2026. Its price fell 51.0% over the past 12 months. The month-end price fell 11.4% over the 3 years through Oct 2026, a compound annual decline of 4.0%.

    Price Chart

    From May 2022 to Oct 2026, its highest month-end close was $2.74 in Oct 2025 and its lowest $1.02 in Sep 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart OKYO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OKYO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 27.2%, and over 6 months it fell 31.3%.

    PeriodChange
    1 month-21.4%
    3 months-27.2%
    6 months-31.3%
    12 months-51.0%
    12 months, with dividends-51.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-11.4%-4.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 80.0%, and its weakest was 2024, when it fell 35.0%.

    YearCloseChange
    2026 through Oct 2026$1.47-29.0%
    2025$2.07+80.0%
    2024$1.15-35.0%
    2023$1.77-7.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 21.1% below its 50-day average of $1.40 and 29.8% below its 200-day average of $1.57.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.10
    50-day average$1.40-21.1%
    200-day average$1.57-29.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 66.4%.

    MeasureValue
    1-year beta1.05
    Largest fall, 1 year-64.6%
    Largest fall, 3 years-66.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About OKYO

    What is OKYO's 1-year price change?

    OKYO Pharma's price fell 51.0% over the past 12 months. With dividends included, the 12-month total return was -51.0%.

    How has OKYO stock done over the long term?

    OKYO Pharma's month-end price fell 11.4% over the 3 years through Oct 2026, a compound annual decline of 4.0%. These figures leave out dividends.

    What is OKYO's beta?

    OKYO Pharma's 1-year beta against the S&P 500 is 1.05, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 64.6%.

    Is the OKYO chart free?

    Yes. Advanced Charting for OKYO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.